Treatment of Stent Restenosis. Moving Beyond Momentum* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 47, Issue 11, 2006, Pages 2161-2163

  Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ATHERECTOMY; BRACHYTHERAPY; CLINICAL TRIAL; DRUG ELUTING STENT; EDITORIAL; HUMAN; IN STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS;

CARDIOLOGY; CORONARY RESTENOSIS; HUMANS; PHARMACEUTICAL PREPARATIONS; STENTS;

EID: 33646924026     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.014     Document Type: Editorial

References (24)

1. Baim D.S., Levine M.J., Leon M.B., Levine S., Ellis S.G., Schatz R.A., and U.S. Palmaz-Schatz Stent Investigators. Management of restenosis within the Palmaz-Schatz coronary stent (the U.S. multicenter experience). Am J Cardiol 71 (1993) 364-366
2. Bossi I., Klersy C., Black A.J., et al. In-stent restenosis. long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 35 (2000) 1569-1576
3. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis. classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
4. Kuntz R.E., Gibson C.M., Nobuyoshi M., and Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 21 (1993) 15-25
5. Shiran A., Mintz G.S., Waksman R., et al. Early lumen loss after treatment of in-stent restenosis. an intravascular ultrasound study. Circulation 98 (1998) 200-203
6. Moussa I., Moses J., Di Mario C., et al., Stenting after Optimal Lesion Debulking (SOLD) Registry. Angiographic and clinical outcome. Circulation 98 (1998) 1604-1609
7. Mehran R., Dangas G., Mintz G.S., et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy. comparative mechanisms and results. Circulation 101 (2000) 2484-2489
8. Dauerman H.L., Baim D.S., Cutlip D.E., et al. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis. Am J Cardiol 82 (1998) 277-284
9. vom Dahl J., Dietz U., Haager P.K., et al. Rotational atherectomy does not reduce recurrent in-stent restenosis. results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-Stent Restenosis Trial (ARTIST). Circulation 105 (2002) 583-588
10. Albiero R., Silber S., Di Mario C., et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis. results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT). J Am Coll Cardiol 43 (2004) 943-949
11. Alfonso F., Zueco J., Cequier A., et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 42 (2003) 796-805
12. Waksman R., Ajani A.E., White R.L., et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
13. Waksman R. Vascular brachytherapy and coronary stenting for de novo lesions. love on the rocks. J Am Coll Cardiol 44 (2004) 538-540
14. Teirstein P.S., Massullo V., Jani S., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 336 (1997) 1697-1703
15. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis. the INHIBIT randomised controlled trial. Lancet 359 (2002) 551-557
16. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
17. Ong A.T., Serruys P.W., Aoki J., et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population. one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141
18. Alfonso F., Pérez-Vizcayno M.-J., Hernandez R., et al., RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 47 (2006) 2152-2160
19. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. a randomized controlled trial. JAMA 293 (2005) 165-171
20. Holmes Jr. D. A multicenter randomized study of the sirolimus-eluting bx velocity stent vs intravascular brachytherapy in the treatment of patients with in-stent restenotic coronary artery lesions (2005). http://www.tctmd.com Available at: http://www.tctmd.com. Accessed March 14, 2006
21. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. a randomized controlled trial. JAMA 294 (2005) 1215-1223
22. Fujii K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation. an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
23. Gogo Jr. P.B., Schneider D.J., Watkins M.W., Terrien E.F., Sobel B.E., and Dauerman H.L. Systemic inflammation after drug-eluting stent placement. J Thromb Thrombolysis 19 (2005) 87-92
24. Sabate M., Jimenez-Quevedo P., Angiolillo D.J., et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients. the Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation 112 (2005) 2175-2183